Columbia Laboratories to Discuss Acquisition of CRINONE® U.S. Marketing Rights on January 4, 2007 Conference Call

Business Wire, Jan 2, 2007

LIVINGSTON, N.J. -- Columbia Laboratories, Inc. (NASDAQ: CBRX) will hold a conference call on January 4, 2007 to discuss its recent acquisition of the U.S. marketing rights to CRINONE([R]) (progesterone gel). Robert S. Mills, Columbia's president and chief executive officer, will host the call.

Access information

[TABLE OMITTED]

Replay

A recording of the conference call will be available two hours after completion until Thursday, January 11, 2007 at 11:59 PM ET at (888) 203-1112 (U.S. only) or (719) 457-0820. The replay password is 6468776. The webcast will be archived for on-demand listening for one year on the Company's website, www.columbialabs.com, under "Events" in the Investor section.

About Columbia Laboratories

Columbia Laboratories, Inc. is a U.S.-based international pharmaceutical company dedicated to the development and commercialization of reproductive healthcare and endocrinology products that use its novel bioadhesive drug delivery technology. For more information, please visit www.columbialabs.com.

CRINONE([R]) is a registered trademark of Columbia Laboratories, Inc.